Beta Bionics SEC filings: 8-K

Filter: All · 8-K · 10-Q · 10-K · Form 4

8-KOct. 27, 2026, 4:04 p.m. ETView on SEC.gov
Results of operations and financial condition · Financial statements and exhibits
AI summary, unreviewedBeta Bionics Q3 2026 Net Sales Rise 30% to $35.5 Million, Beating Consensus; Full-Year Revenue Guidance Low End Raised to $124 Million
8-KSept. 16, 2026, 6:24 p.m. ETView on SEC.gov
Other events · Financial statements and exhibits
8-KSept. 15, 2026, 4:58 p.m. ETView on SEC.gov
Regulation FD disclosure · Other events · Financial statements and exhibits
8-KJuly 29, 2026, 4:04 p.m. ETView on SEC.gov
Results of operations and financial condition · Financial statements and exhibits